LQDA Liquidia Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: LQDA

Price (delayed)

$7.14

Market cap

$463.43M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.87

Enterprise value

$435.7M

Liquidia Corporation is a biopharmaceutical company focused on the development and commercialization of products in pulmonary hypertension and other applications of its PRINT technology. The Company operates through two subsidiaries, ...

Highlights
LQDA's gross profit is up by 44% year-on-year and by 4.5% since the previous quarter
LQDA's revenue is up by 33% YoY and by 2.9% QoQ
The quick ratio has shrunk by 52% YoY but it is up by 38% QoQ
The company's debt has surged by 97% YoY and by 29% QoQ
LQDA's equity is down by 49% year-on-year and by 21% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://liquidia.com
Peers: OMGA

Key stats

What are the main financial stats of LQDA
Market
Shares outstanding
64.91M
Market cap
$463.43M
Enterprise value
$435.7M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
9.63
Price to sales (P/S)
25.28
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
23.79
Earnings
Revenue
$18.32M
EBIT
-$52.58M
EBITDA
-$49.96M
Free cash flow
-$31.76M
Per share
EPS
-$0.87
Free cash flow per share
-$0.49
Book value per share
$0.74
Revenue per share
$0.28
TBVPS
$1.61
Balance sheet
Total assets
$111.64M
Total liabilities
$63.64M
Debt
$48.5M
Equity
$48.01M
Working capital
$70.82M
Liquidity
Debt to equity
1.01
Current ratio
6.83
Quick ratio
6.55
Net debt/EBITDA
0.55
Margins
EBITDA margin
-272.8%
Gross margin
85.9%
Net margin
-314.4%
Operating margin
-291.8%
Efficiency
Return on assets
-46.9%
Return on equity
-82.1%
Return on invested capital
-100.5%
Return on capital employed
-52.8%
Return on sales
-287%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

LQDA stock price

How has the Liquidia stock price performed over time
Intraday
0.99%
1 week
6.25%
1 month
15.16%
1 year
47.52%
YTD
12.09%
QTD
12.62%

Financial performance

How have Liquidia's revenue and profit performed over time
Revenue
$18.32M
Gross profit
$15.73M
Operating income
-$53.45M
Net income
-$57.59M
Gross margin
85.9%
Net margin
-314.4%
LQDA's gross profit is up by 44% year-on-year and by 4.5% since the previous quarter
LQDA's revenue is up by 33% YoY and by 2.9% QoQ
LQDA's net income is down by 25% YoY and by 13% from the previous quarter
LQDA's operating income is down by 22% year-on-year and by 13% since the previous quarter

Growth

What is Liquidia's growth rate over time

Valuation

What is Liquidia stock price valuation
P/E
N/A
P/B
9.63
P/S
25.28
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
23.79
Liquidia's EPS has decreased by 13% QoQ and by 6% YoY
The stock's P/B is 59% above its 5-year quarterly average of 6.0 and 42% above its last 4 quarters average of 6.7
LQDA's equity is down by 49% year-on-year and by 21% since the previous quarter
LQDA's revenue is up by 33% YoY and by 2.9% QoQ
The stock's price to sales (P/S) is 26% less than its 5-year quarterly average of 33.6

Efficiency

How efficient is Liquidia business performance
The ROE has contracted by 42% YoY and by 32% from the previous quarter
The ROA has contracted by 18% from the previous quarter and by 17% YoY
Liquidia's return on sales has increased by 10% YoY but it has decreased by 9% QoQ
The ROIC has grown by 3.4% YoY

Dividends

What is LQDA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LQDA.

Financial health

How did Liquidia financials performed over time
The total assets is 75% more than the total liabilities
The company's total liabilities has surged by 70% YoY and by 4.4% QoQ
The quick ratio has shrunk by 52% YoY but it is up by 38% QoQ
The company's debt has surged by 97% YoY and by 29% QoQ
The debt to equity has soared by 63% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.